Literature DB >> 28179064

GABA and schizophrenia: Where we stand and where we need to go.

Jill R Glausier1, David A Lewis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28179064      PMCID： PMC5365350          DOI： 10.1016/j.schres.2017.01.050

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  15 in total

1.  Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.

Authors:  Klaus Oliver Schubert; Melanie Föcking; David R Cotter
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

Review 2.  Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

Authors:  James M McNally; Robert W McCarley
Journal:  Curr Opin Psychiatry       Date:  2016-05       Impact factor: 4.741

3.  Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.

Authors:  Danko Georgiev; Toru Yoshihara; Rika Kawabata; Takurou Matsubara; Makoto Tsubomoto; Yoshio Minabe; David A Lewis; Takanori Hashimoto
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

4.  In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

Authors:  W Gordon Frankle; Raymond Y Cho; Konasale M Prasad; N Scott Mason; Jennifer Paris; Michael L Himes; Christopher Walker; David A Lewis; Rajesh Narendran
Journal:  Am J Psychiatry       Date:  2015-07-02       Impact factor: 18.112

5.  Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia.

Authors:  John F Enwright; Sowmya Sanapala; Aaron Foglio; Raissa Berry; Kenneth N Fish; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2016-02-12       Impact factor: 7.853

6.  DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.

Authors:  E Dong; W B Ruzicka; D R Grayson; A Guidotti
Journal:  Schizophr Res       Date:  2014-12-02       Impact factor: 4.939

Review 7.  Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders?

Authors:  Zhen Yan; Eunjoon Kim; Dibyadeep Datta; David A Lewis; Scott H Soderling
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

Review 8.  Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Authors:  Sabina Berretta; Harry Pantazopoulos; Matej Markota; Christopher Brown; Eleni T Batzianouli
Journal:  Schizophr Res       Date:  2015-01-16       Impact factor: 4.939

9.  Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.

Authors:  Daniel W Chung; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-07-22       Impact factor: 18.112

10.  Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression.

Authors:  Daniel W Chung; David W Volk; Dominique Arion; Yun Zhang; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2015-09-04       Impact factor: 18.112
View more
  12 in total

1.  Altered selection during language processing in individuals at high risk for psychosis.

Authors:  Teresa Vargas; Hannah Snyder; Marie Banich; Rae Newberry; Stewart A Shankman; Gregory P Strauss; Vijay Anand Mittal
Journal:  Schizophr Res       Date:  2018-06-20       Impact factor: 4.939

2.  Altered Parvalbumin Basket Cell Terminals in the Cortical Visuospatial Working Memory Network in Schizophrenia.

Authors:  Kenneth N Fish; Brad R Rocco; Adam M DeDionisio; Samuel J Dienel; Robert A Sweet; David A Lewis
Journal:  Biol Psychiatry       Date:  2021-02-19       Impact factor: 12.810

3.  Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.

Authors:  Masayuki Baba; Kazumasa Yokoyama; Kaoru Seiriki; Yuichiro Naka; Kensuke Matsumura; Momoka Kondo; Kana Yamamoto; Misuzu Hayashida; Atsushi Kasai; Yukio Ago; Kazuki Nagayasu; Atsuko Hayata-Takano; Akinori Takahashi; Shun Yamaguchi; Daisuke Mori; Norio Ozaki; Tadashi Yamamoto; Kazuhiro Takuma; Ryota Hashimoto; Hitoshi Hashimoto; Takanobu Nakazawa
Journal:  Neuropsychopharmacology       Date:  2019-06-19       Impact factor: 7.853

Review 4.  Are CB2 Receptors a New Target for Schizophrenia Treatment?

Authors:  Isadora L Cortez; Naielly Rodrigues da Silva; Francisco S Guimarães; Felipe V Gomes
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

Review 5.  Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia.

Authors:  Nina Vanessa Kraguljac; Adrienne Carol Lahti
Journal:  Front Psychiatry       Date:  2021-03-11       Impact factor: 5.435

Review 6.  Attractor cortical neurodynamics, schizophrenia, and depression.

Authors:  Edmund T Rolls
Journal:  Transl Psychiatry       Date:  2021-04-12       Impact factor: 6.222

7.  Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction.

Authors:  Shekib A Jami; Scott Cameron; Jonathan M Wong; Emily R Daly; A Kimberley McAllister; John A Gray
Journal:  J Neurophysiol       Date:  2021-05-26       Impact factor: 2.714

Review 8.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

Authors:  A Nieto; T Bailey; K Kaczanowska; P McDonald
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 9.  Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis.

Authors:  Enrico Patrono; Jan Svoboda; Aleš Stuchlík
Journal:  Behav Brain Funct       Date:  2021-06-22       Impact factor: 3.759

Review 10.  PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders.

Authors:  Brielle R Ferguson; Wen-Jun Gao
Journal:  Front Neural Circuits       Date:  2018-05-16       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.